Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]

Alekseeva AA, Moiseeva EV, Onishchenko NR, et al. Int J Nanomedicine. 2017;12:3735–3749. On page 3735, the first author’s name was incorrectly listed as Anna A Alekseeva. Her correct name is Anna S Alekseeva.Read the original article

Guardado en:

Detalles Bibliográficos
Autores principales:	Alekseeva AS, Moiseeva EV, Onishchenko NR, Boldyrev IA, Singin AS, Budko AP, Shprakh ZS, Molotkovsky JG, Vodovozova EL
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/192b5a72de474305ab6c722fe48734dc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:192b5a72de474305ab6c722fe48734dc
record_format	dspace
spelling	oai:doaj.org-article:192b5a72de474305ab6c722fe48734dc2021-12-02T01:34:06ZLiposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]1178-2013https://doaj.org/article/192b5a72de474305ab6c722fe48734dc2017-07-01T00:00:00Zhttps://www.dovepress.com/httpscorrigendum-wwwdovepresscomliposomal-formulation-of-a--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Alekseeva AA, Moiseeva EV, Onishchenko NR, et al. Int J Nanomedicine. 2017;12:3735–3749. On page 3735, the first author’s name was incorrectly listed as Anna A Alekseeva. Her correct name is Anna S Alekseeva.Read the original articleAlekseeva ASMoiseeva EVOnishchenko NRBoldyrev IASingin ASBudko APShprakh ZSMolotkovsky JGVodovozova ELDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 5119-5120 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Alekseeva AS Moiseeva EV Onishchenko NR Boldyrev IA Singin AS Budko AP Shprakh ZS Molotkovsky JG Vodovozova EL Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
description	Alekseeva AA, Moiseeva EV, Onishchenko NR, et al. Int J Nanomedicine. 2017;12:3735–3749. On page 3735, the first author’s name was incorrectly listed as Anna A Alekseeva. Her correct name is Anna S Alekseeva.Read the original article
format	article
author	Alekseeva AS Moiseeva EV Onishchenko NR Boldyrev IA Singin AS Budko AP Shprakh ZS Molotkovsky JG Vodovozova EL
author_facet	Alekseeva AS Moiseeva EV Onishchenko NR Boldyrev IA Singin AS Budko AP Shprakh ZS Molotkovsky JG Vodovozova EL
author_sort	Alekseeva AS
title	Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
title_short	Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
title_full	Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
title_fullStr	Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
title_full_unstemmed	Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
title_sort	liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse t-cell leukemic lymphoma [corrigendum]
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/192b5a72de474305ab6c722fe48734dc
work_keys_str_mv	AT alekseevaas liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum AT moiseevaev liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum AT onishchenkonr liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum AT boldyrevia liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum AT singinas liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum AT budkoap liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum AT shprakhzs liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum AT molotkovskyjg liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum AT vodovozovael liposomalformulationofamethotrexatelipophilicprodrugassessmentintumorcellsandmousetcellleukemiclymphomacorrigendum
_version_	1718403001748553728

Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]

Ejemplares similares